Terry Dwyer, CDAH Study

Chair of i3C Consortium Steering Committee. Executive Director, The George lnstitute for Global Health, University of Oxford. Professor of Epidemiology, University of Oxford. His international roles have included Chair of the WHO’s Western Pacific Region Advisory Committee on Health Research and a member of the WHO’s Global Advisory Committee on Health Research. Professor Dwyer is currently a member of the UK Biobank International Scientific Advisory Board, and Director of the data coordinating centre and member of the Steering Committee for I4C (International Childhood Cancer Cohort Consortium).

 

Olli Raitakari, Young Finns Study

Head of i3C Data Coordinating Centre. Specialist in Clinical Physiology, Head of the Department of Clinical Physiology and Deputy Head of the Division of Clinical Physiology, Nuclear Medicine and PET (Turku University Hospital), Professor in Cardiovascular Medicine and Director of the Turku University Cardiovascular Centre of Applied and Preventive Medicine (University of Turku), Academy Professor, Coordinator of the national multi-centre study the Cardiovascular Risk in Young Finns, Deputy Director of the STRIP study.

 

 

Lydia Bazzano, Bogalusa Heart Study

As a clinician-investigator trained in Epidemiology and board certified in Internal Medicine, Dr. Bazzano has expertise in a broad range of clinical research with a focus on cardiovascular disease and its risk factors. Her primary emphasis has been on the role of dietary and metabolic factors such as obesity, lipids and glucose in the development of vascular disease. She has been working with the Bogalusa Heart Study program since 2010 and currently serve as the Chair of the Bogalusa Heart Study Program Steering Committee and is investigating the role of vascular aging in cognitive and physical performance in the Bogalusa Heart Study cohort. She is a native of Louisiana, and helped to establish the new 7,000 square foot research clinic in which the Bogalusa Heart Study Program is housed. Dr. Bazzano has published more than 80 peer-reviewed research papers and has substantial experience in the design and conduct of both observational studies and randomized controlled trials in community settings.

 

Gerald Berenson, Bogalusa Heart Study

Director, Tulane Center for Cardiovascular Health and Professor of Epidemiology, Medicine (Cardiology), Pediatrics and Biochemistry, Tulane University School of Medicine, and Principal Investigator of the Bogalusa Heart Study since 1973. Dr. Berenson has published widely on the epidemiology of cardiovascular disease and type 2 diabetes (more than 1000 peer-reviewed publications).

 

 

Trudy Burns, Muscatine Study

Professor, College of Public Health, Carver College of Medicine, and College of Nursing, The University of Iowa. Dr. Burns is trained as a biostatistician/genetic epidemiologist. Her research career has focused primarily on cardiovascular disease epidemiology as reflected in her more than 25-year involvement with The Muscatine Study, for which is now the Principal Investigator. Dr. Burns has served on numerous NIH grant review committees and monitoring boards, and she is a Fellow of the American Heart Association. She is an author/co-author on more than 130 peer-reviewed publications and on 17 book chapters and she is the co-editor of the book Pediatric Prevention of Atherosclerotic Cardiovascular Disease, 2006, Oxford University Press, along with Dr. Ronald Lauer, founder of The Muscatine Study, and Dr. Stephen Daniels.

 

Wei Chen, Bogalusa Heart Study

Professor of Epidemiology, Tulane University School of Public Health and Tropical Medicine. Dr. Chen is currently a senior investigator with the Bogalusa Heart Study; his involvement began in 1995. He is Principal Investigator of two ongoing NIH funded research projects. Dr. Chen has published widely on genetic epidemiology of cardiovascular disease risk factors (more than 130 peer-reviewed publications).

 

 

Stephen Daniels, NGHS

Professor and Chairman, Department of Pediatrics University of Colorado Denver School of Medicine. Dr. Daniels is an expert in preventive cardiology, with a longtime interest in the application of sophisticated epidemiologic and biostatistical methods to pediatric clinical research problems. His studies have focused on better understanding the causes of blood pressure elevation and cholesterol abnormalities in children and adolescents, particularly the role that obesity may play in these health issues. He has been an author of numerous articles presenting evidence-based clinical guidelines related to cardiovascular disease prevention and treatment.

 

 

David R. Jacobs, Jr.

David R. Jacobs, Jr., PhD (Mathematical Statistics, 1971, The Johns Hopkins University) has been on the faculty of the School of Public Health, University of Minnesota since 1974. He holds a Mayo Professorship in Public Health.  He concurrently holds a guest professorship at the Department of Nutrition at the University of Oslo, Norway (1999-present). He is a fellow of the American Heart Association and the American College of Nutrition.  He was Deputy Editor of the British Journal of Nutrition (2006-2011) and is on the editorial boards of Circulation, Clinical Chemistry, Preventive Medicine, and other journals.

He has over 900 articles on various topics concerning the epidemiology of chronic diseases and their risk factors, including the epidemiology of specific molecules, and particularly those relating to cardiovascular diseases and diabetes.  Topics of interest include arterial elasticity; measures related to oxidative stress and damage, serum antioxidant vitamins, gamma glutamyl transferase, plasma F2-isoprostanes, C-reactive protein, adiponectin, persistent organic pollutants, monitoring of cardiovascular disease and its risk factors, and the relation of high cholesterol with atherosclerotic diseases and the relation of low cholesterol with nonatherosclerotic diseases. 

In his studies of nutrition, he focused early on whole grain intake and health.  His work was influential in the 2000 decision of the USDA Dietary Guidelines Advisory Committee to add a specific guideline to "eat a variety of grains, especially whole grains", and in the strengthening of this message in the 2005 and 2010 USDA Dietary Guidelines. Since 2000, he has written several articles on the health implications of synergies of different plant foods and dietary patterns.

 

 

Markus Juonala, Young Finns Study

Secretary of i3C Consortium Steering Committee, Specialist in Internal Medicine and Endocrinology, Professor of Internal Medicine at the University of Turku, Board member of the Finnish Atherosclerosis Society. His research work has focused on associations between childhood cardiovascular risk factors and early markers of subclinical atherosclerosis. He has more than 150 peer-reviewed publications since his first in 2003. He has been awarded with several young scientist prizes.

 
Costan Magnussen, CDAH and Young Finns Study

Postdoctoral Research Fellow at the Menzies Research Institute. Costan is an early-career researcher having completed his PhD in epidemiology in 2009. His PhD and postdoctoral work has focused on the pediatric origin of adult cardio-metabolic disease using i3C data. He has previously consulted on 2 non-communicable disease surveys as part of a 6-month placement in Vietnam, completed an internship on physical activity at the headquarters of the World Health Organization in Geneva, and has more than 50 peer-reviewed papers published or in press.
 

 

John Morrison, Princeton Lipid Research Clinics Study

Emeritus Professor of Pediatrics, Division of Cardiology, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati Medical Center.  Dr. Morrison’s work has focused on the appearance in childhood of CVD risk factors for adult disease, changes over time, and outcomes.  He began his career with the NHLBI Lipid Research Clinics Program, serving as co PI and Project Director of the Princeton Prevalence Studies (1973-1983), a multi-stage epidemiological survey of lipids and other CVD risk factors in schoolchildren and their parents.  Building on suggestive findings from the LRC, he followed this study with a 3-year study of adolescent changes in sex hormones and obesity and their effects on male plasma lipid profiles. In 1985 he began planning the NHLBI Growth and Health Study (NGHS) with the NHLBI Program Office and other Principal Investigators of clinical sites and the coordinating center, which eventually grew to a 10-year cohort study.   In the Princeton Follow-up Study, he assessed changes in familial correlations of CVD risk factors from the period of the shared household to that of separate households.  He is currently conducting a second follow-up of the Princeton cohort, 10 years after the PFS.

 

 

Matthew Sabin, Young Finns Study

Paediatric Endocrinologist with clinical and basic science research interests in the metabolic health consequences of childhood obesity. He completed his PhD in 2006 and is currently an NHMRC Postdoctoral Training Fellow at the Murdoch Childrens Research Institute, as well as a Lecturer in Physiology at Monash University, Melbourne, Australia. He leads Australia's largest tertiary-hospital based paediatric obesity service at The Royal Children's Hospital in Melbourne and is regarded nationally and internationally as an expert in the clinical management of paediatric obesity. He has more than 40 published peer-reviewed papers.

 

Nicholas Schork, Bogalusa Heart Study

Dr. Schork is Professor, Molecular and Experimental Medicine, The Scripps Research Institute and the Director of Biostatistics and Bioinformatics at the Scripps Translational Science Institute in La Jolla, California. Dr Schork has more than 300 publications in the areas of applied and theoretical statistical genetics. He has a long history of collaborative research in which his role has been to oversee the development, implementation, and application of bioinformatics and data analysis methodologies. For example, he is Director of biostatistics and bioinformatics for the NIA-sponsored Longevity Consortium, director of statistical genetics for the NIMH-sponsored Bipolar Genetics Study (BIGS), and director of biostatistics for the San Diego Autism Center of Excellence.

 

Alan Sinaiko, Minneapolis Childhood Cohort Studies 

Dr. Sinaiko is a Pediatric Nephrologist and Professor at the University of Minnesota. He has been a member of the NHLBI Task Forces on Blood Pressure Control in Children in 1987, 1996, and 2004; the NIH/NICHD Pediatric Hypertension Treatment Working Group 2006-07; and the NIH/NICHD Pediatric Metabolic Syndrome Working Group 2006-08. He has been funded by NIH since 1985 to study the influence of obesity and insulin resistance in childhood on development of cardiovascular risk in adulthood.

 

Sathanur Srinivasan, Bogalusa Heart Study

Professor of Epidemiology and Biochemistry, Tulane University School of Public Health and Tropical Medicine, senior investigator with the Bogalusa Heart Study since 1973 and Associate Director of Tulane Center for Cardiovascular Health. Dr. Srinivasan has published widely on epidemiology and biochemistry of cardiovascular disease and type 2 diabetes (more than 400 peer-reviewed publications).

 

Julia Steinberger, Minneapolis Childhood Cohort Studies

Professor of Pediatrics, Dwan Chair of Pediatric Cardiology, University of Minnesota Amplatz Children's Hospital. Dr. Steinberger is the director of the Pediatric Preventive Cardiology Program and the Director of Pediatric Echocardiography at the University of Minnesota. She is the Chair of the Atherosclerosis, Hypertension Obesity in Youth Committee of the American Heart Association. She has extensive experience in CV risk factor research and is currently the PI of two NIH (R01) funded large-scale studies of CV risk in healthy and high-risk populations.

 

 

 

Cong Sun, CDAH Study

Cong Sun, MD, PhD, is currently a NHMRC research fellow based at Murdoch Children’s Research Institute, Melbourne, Australia. She received her medical degree from Nanjing University, following by a residency in ophthalmology. Dr Sun completed her MPH and then PhD at the University of Melbourne in 2010. Her PhD examined the genetic and environmental determinants of a novel marker for microvascular changes associated with systemic vascular diseases. Her research interests extend to cardiovascular epidemiology.

 

 

Elaine Urbina, Princeton Lipid Research Clinics Study, Formerly with Bogalusa Heart Study

Associate Professor of Pediatrics, Director of Preventive Cardiology in The Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati Ohio.  Dr. Urbina is a pediatric cardiologist with interest in the epidemiology CV risk factors starting in childhood.  She was a co-investigator in the Bogalusa Heart Study for over a decade before she was recruited to Cincinnati to expand the non-invasive imaging capabilities of their research laboratory.  Her clinical expertise in the treatment of high cholesterol and blood pressure in youth led to her inclusion on committees setting guidelines for the evaluation of CV risk in children in the United States (American Heart Association, American College of Cardiology and National Institutes of Health). Her current research concentrates on new techniques to evaluate  arterial structure and function in high risk adolescents with high blood pressure, cholesterol, obesity and type 2 diabetes mellitus. Dr. Urbina is currently working closely with Drs. Morrison and Woo to assist in continuing work with the two Cincinnati longitudinal cohorts (Lipid Research Clinics/Princeton Follow-up Study and the NHLBI Growth and Health Study). She also provides consultation on echo and vascular measures previously collected as part of the Bogalusa Heart Study.

 

 

 

Alison Venn, CDAH Study

Alison is an epidemiologist whose early research training was in immunology and biochemistry in the UK and Australia. She is Deputy Director of the Menzies Research Institute, Tasmania, and Director of the Tasmanian Cancer Registry. Her research interests are in the epidemiology of chronic disease and reproductive health. She has led major longitudinal studies including a study of cancer incidence in 30,000 Australian IVF patients, an investigation of the long-term health effects of estrogen treatment to reduce the adult height of tall girls, and the Childhood Determinants of Adult Health (CDAH) study. She is lead investigator of a study investigating the effectiveness of the Tasmanian State Government’s Healthy@Work program which aims to reduce chronic disease risk in 30,000 employees.

 

 

Jorma Viikari, Young Finns Study

Specialist in internal medicine and endocrinology, Emeritus Professor of Medicine in the University of Turku, Finland. Coordinator of the Cardiovascular Risk in Young Finns Study since 1978, member of the Steering Committee of the STRIP-study (Special Turku coronary Risk factor Intervention Project) since 1989.

 

Jessica Woo, Princeton Lipid Research Clinics Study

Assistant Professor of Pediatrics, Division of Biostatistics and Epidemiology and The Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio. Dr. Woo is a molecular/genetic epidemiologist with particular interest in the developmental pathways leading to childhood obesity. She has developed a research program in longitudinal development of obesity and its comorbidities, including consideration of molecular biomarkers, genetics/epigenetics and the role of early life dietary exposures, such as breastfeeding and the composition of human milk.  Dr. Woo is currently working closely with Dr. Morrison to assume leadership for two longitudinal cohorts in Cincinnati: the Lipid Research Clinics/Princeton Follow-up Study (LRC/PFS) and the NHLBI Growth and Health Study (NGHS).

 

Copyright 2011 i3C Consortium | Webdesign graafi.net